CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/07/2023
Back to search
Official data from USPTO
STRAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STRAGEN
ST13
US500000079121314Class
1, 5, 35, 42, 44, 45
Filing
79121314
Registration
4449450
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
42
Latest update
06/07/2023
Trademark type
Word
Nice classes
1, 5, 35, 42, 44, 45
Filing date
10/09/2012
Registration date
12/17/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/26/2021
Last transaction
02/26/2021
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH-1228 Plan-Les-Ouates, CH
Examiner
LOBO, DEBORAH
Law office
L90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Stragen Pharma S.A.
Representatives
Katzarov SA
Technical classification
Nice Classes
Class 1Class 5Class 35Class 42Class 44Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical preparations for industrial and scientific useincluding for diagnostic use; chemical reagents other than for medical or veterinary use; diagnostic preparationsother than for medical or veterinary use; chemical substancesreagents for chemical analysis in laboratories
Class 5
Pharmaceutical preparations and substancesantibioticsanticonvulsantsantiepileptic preparations and substances for the treatment of cardiological diseasesbone diseasesoncologygynecologyrhumatologyphlebology and dermatological disorders and diseases; chemical reagents for medical and veterinary use; diagnostic preparations for medical and veterinary use
Class 35
Administrative processing of applications for marketing release authorization and regulatory approval of pharmaceutical and medical products; electronic data collection and data submission services for commercial purposes provided in connection with clinical researchtestingtrials and finalization of pharmaceutical productsmedical devices and biotechnology
Class 42
Consulting in the field of pharmaceutical science; researchdesign and development in the medical and pharmaceutical field; development of medicines for others; conducting clinical and preclinical trials and supervision of clinical and preclinical trials; development of medicines in compliance with regulatory requirements; conducting clinical trials for others in the field of medicine compatibility; pharmacovigilance services for othersmonitoring the quality and efficacy of pharmaceutical preparations; consultancy in the field of medical and pharmaceutical research; providing advice in connection with clinical trial researchtesting and evaluation of pharmaceutical productsmedical devices and biotechnology; evaluating medicines of others to assure compliance with regulatory requirements; providing data analysis of data obtained in connection with clinical trial research and testing of pharmaceutical productsmedical devices and biotechnology; scientific research relating to the evaluation of new medicines; development of pharmaceutical preparationsremedies and medicines; technological servicesscientific researchanalysis and testing in the pharmaceutical and health care sector; scientific research and analysisconducting early evaluations in the field of new pharmaceutical preparations; scientific research and development in the pharmaceutical field; scientific research and developmentconducting clinical trials of medicines of others; product development in the field of medicine
Class 44
Consultancy in the field of medical treatments and advice in the pharmaceutical field
Class 45
Regulatory compliance consultancy in the field of pharmaceutical productsmedical devices and biotechnology products
Publications
History of USPTO decisions and trademark events.
42 publications found
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
04/11/2023
FINP
FINAL DECISION TRANSACTION PROCESSED BY IB
04/05/2023
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/11/2023
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/11/2023
XXCR
GENERIC MADRID TRANSACTION CREATED
01/11/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/01/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/26/2021
C71T
CANCELLED SECTION 71
02/26/2021
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
05/08/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/15/2018
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/13/2014
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/09/2014
FIMP
FINAL DISPOSITION PROCESSED
05/09/2014
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/17/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2013
PUBO
PUBLISHED FOR OPPOSITION
10/01/2013
GPNX
NOTIFICATION PROCESSED BY IB
09/30/2013
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/11/2013
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/11/2013
NPUB
NOTICE OF PUBLICATION
09/11/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/27/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/27/2013
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/26/2013
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/26/2013
ALIE
ASSIGNED TO LIE
08/16/2013
NREV
NOTICE OF REVIVAL - MAILED
08/14/2013
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/14/2013
PETG
PETITION TO REVIVE-GRANTED
08/14/2013
PROA
TEAS PETITION TO REVIVE RECEIVED
08/14/2013
ATRV
ATTORNEY REVIEW COMPLETED
05/10/2013
LIMS
LIMITATION OF GOODS/SERVICES FROM IB ENTERED
05/10/2013
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
04/20/2013
RFNT
REFUSAL PROCESSED BY IB
02/27/2013
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/05/2013
RFRR
REFUSAL PROCESSED BY MPU
02/05/2013
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/05/2013
CNRT
NON-FINAL ACTION WRITTEN
02/04/2013
DOCK
ASSIGNED TO EXAMINER
02/04/2013
MAFR
APPLICATION FILING RECEIPT MAILED
12/18/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/12/2012
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/07/2012
Continuous trademark protection
Get notified about every new filing that threatens STRAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.